BR0016796A - Composições antimicrobianas e métodos de uso - Google Patents

Composições antimicrobianas e métodos de uso

Info

Publication number
BR0016796A
BR0016796A BR0016796-7A BR0016796A BR0016796A BR 0016796 A BR0016796 A BR 0016796A BR 0016796 A BR0016796 A BR 0016796A BR 0016796 A BR0016796 A BR 0016796A
Authority
BR
Brazil
Prior art keywords
methods
compositions
infectivity
relates
present
Prior art date
Application number
BR0016796-7A
Other languages
English (en)
Inventor
James R Baker Jr
Terek Hamouda
Amy Shih
Myc Andrzej
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of BR0016796A publication Critical patent/BR0016796A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

"COMPOSIçõES ANTIMICROBIANAS E MéTODOS DE USO". A presente invenção relaciona-se às composições e aos métodos para diminuir a infecciosidade, a morbidade, e a taxa de mortalidade associadas com uma variedade de organismos e vírus patogênicos. A presente invenção também relaciona-se aos métodos e às composições para descontaminar áreas colonizadas ou de outra forma infectadas por organismos e virus patogênicos. Ademais, a presente invenção relaciona-se aos métodos e às composições para diminuir a infecciosidade de organismos patogênicos em gêneros alimentícios. Em particular, a infecciosidade de organismos patogênicos, a morbidade, e a mortalidade diminuídas são efetuadas contatando-se o organismo patogênico com uma nanoemulsão de óleo em água compreendendo um óleo, um solvente orgânico, e um tensoativo disperso em uma fase aquosa.
BR0016796-7A 1999-12-30 2000-12-29 Composições antimicrobianas e métodos de uso BR0016796A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47486699A 1999-12-30 1999-12-30
US09/561,111 US6506803B1 (en) 1999-04-28 2000-04-28 Methods of preventing and treating microbial infections
PCT/US2000/035651 WO2001049296A1 (en) 1999-12-30 2000-12-29 Antimicrobial compositions and methods of use

Publications (1)

Publication Number Publication Date
BR0016796A true BR0016796A (pt) 2003-06-10

Family

ID=27044598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016796-7A BR0016796A (pt) 1999-12-30 2000-12-29 Composições antimicrobianas e métodos de uso

Country Status (12)

Country Link
US (1) US6506803B1 (pt)
EP (2) EP2364709B1 (pt)
JP (2) JP5013495B2 (pt)
CN (1) CN1433314B (pt)
AU (1) AU2609901A (pt)
BR (1) BR0016796A (pt)
CA (1) CA2395678C (pt)
DK (1) DK1242095T3 (pt)
ES (1) ES2425971T3 (pt)
HK (1) HK1055897A1 (pt)
MX (1) MXPA02006564A (pt)
WO (1) WO2001049296A1 (pt)

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236335B2 (en) * 1999-04-28 2012-08-07 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
KR20020038771A (ko) * 1999-09-24 2002-05-23 장 스테판느 비내 인플루엔자 바이러스 백신
US6794352B2 (en) 2000-06-12 2004-09-21 Jeffrey S. Svendsen Cleaning towel having a color identifying label and sanitizer release polymer composition
US7314624B2 (en) * 2001-06-05 2008-01-01 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
BR0212163A (pt) * 2001-08-28 2004-12-07 Eden Reseaech Plc Composição para tratamento ou prevenção de infecção em plantas
US7745686B2 (en) 2001-11-02 2010-06-29 Playtex Products, Inc. Catamenial device
US7799968B2 (en) * 2001-12-21 2010-09-21 Kimberly-Clark Worldwide, Inc. Sponge-like pad comprising paper layers and method of manufacture
US20030175318A1 (en) * 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
EP1494528B1 (en) * 2002-04-17 2006-10-18 Agribiotec s.r.l. Use of vegetable oil as an adjuvant for substances having a fungicide, bactericide, insecticide and herbicide activity
GB0213097D0 (en) 2002-06-07 2002-07-17 Autoglym Improvements in or relating to organic matter
US20040111817A1 (en) * 2002-12-17 2004-06-17 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US7994079B2 (en) * 2002-12-17 2011-08-09 Kimberly-Clark Worldwide, Inc. Meltblown scrubbing product
MXPA05009507A (es) 2003-03-05 2006-03-10 Byocoat Entpr Inc Solucion y proceso antimicrobianos.
WO2005002337A1 (en) * 2003-04-02 2005-01-13 Virtual Drug Development, Inc. Disinfectant compositions and methods
US20040204496A1 (en) * 2003-04-11 2004-10-14 Ammon Daniel M. Disinfecting solutions effective against bacterial endospores
WO2005027872A2 (en) * 2003-06-04 2005-03-31 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US7348097B2 (en) * 2003-06-17 2008-03-25 Medtronic, Inc. Insulative feed through assembly for electrochemical devices
EP1648412B1 (en) * 2003-07-07 2007-11-14 Nares AB Microemulsions and its use for preventing airway diseases
US8211448B2 (en) * 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
WO2005046738A2 (en) * 2003-11-07 2005-05-26 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050129897A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050130536A1 (en) * 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Disposable scrubbing product
US20050136772A1 (en) * 2003-12-23 2005-06-23 Kimberly-Clark Worldwide, Inc. Composite structures containing tissue webs and other nonwovens
AU2005207622B2 (en) 2004-01-23 2010-10-28 Eden Research Plc Methods of killing nematodes comprising the application of a terpene component
US7707931B2 (en) * 2004-04-06 2010-05-04 West Liberty Foods, L.L.C. Clean room food processing systems, methods and structures
SI1753529T1 (sl) * 2004-05-20 2013-12-31 Eden Research Plc Sestavki, ki vsebujejo votli delec glukana ali votli delec stene celice, ki enkapsulira komponento terpena, postopki njihove izdelave in uporabe
US20050260138A1 (en) * 2004-05-21 2005-11-24 Virgil Flanigan Producton and use of a gaseous vapor disinfectant
NZ534007A (en) * 2004-07-09 2007-06-29 Horticulture & Food Res Inst Fungicidal composition comprising anhydrous milk fat (AMF) and soybean oil for the treatment of Powdery Mildew
US20060135026A1 (en) * 2004-12-22 2006-06-22 Kimberly-Clark Worldwide, Inc. Composite cleaning products having shape resilient layer
US20060204469A1 (en) * 2005-03-09 2006-09-14 Eric Spengler Stable mixed emulsions
US20070054834A1 (en) * 2005-04-11 2007-03-08 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
US20060292248A1 (en) * 2005-06-20 2006-12-28 Bio-Germ Protection, Llc Biological attack protection kit and method
US20070015738A1 (en) * 2005-07-15 2007-01-18 Walker Stephen G Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
EP1951200A2 (en) * 2005-08-09 2008-08-06 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
KR101239057B1 (ko) * 2005-09-03 2013-03-05 비오코트 엔터프라이지스, 인크. 항균 용액 및 이에 관련된 방법
WO2007040598A2 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
WO2007063268A1 (en) 2005-11-30 2007-06-07 Eden Research Plc Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
MX2008006927A (es) 2005-11-30 2008-10-24 Eden Research Plc Composiciones que contienen terpenos y metodos para hacer y usar los mismos.
TWI458495B (zh) * 2006-03-23 2014-11-01 Glaxosmithkline Llc 牙齒器具清潔劑
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) * 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US20080038295A1 (en) * 2006-04-13 2008-02-14 Regents Of The University Of Michigan Compositions and methods for orthopox virus vaccination
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
CN101032507B (zh) * 2007-04-06 2010-09-29 西北农林科技大学 一种红霉素纳米乳抗菌药物及其制备方法
US8747872B2 (en) * 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP2011518184A (ja) * 2008-04-18 2011-06-23 ナノバイオ コーポレーション ヘルペスウイルス感染の治療方法
CA2721800A1 (en) 2008-04-21 2009-10-29 Nanobio Corporation Nanoemulsion influenza vaccine
US20090269394A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Methods and compositions for treating onchomycosis
WO2009132342A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
CA2725381A1 (en) * 2008-05-23 2010-03-25 The Regents Of The University Of Michigan Nanoemulsion adjuvants
CA2725329C (en) 2008-05-23 2013-10-01 The Regents Of The University Of Michigan Nanoemulsion vaccines
FR2933104B1 (fr) * 2008-06-26 2015-10-09 Biomerieux Sa Milieu de culture comportant un compose inhibiteur ou retardateur de germination de spores
US20100092526A1 (en) * 2008-09-26 2010-04-15 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
EP2349285B1 (en) 2008-10-10 2016-03-23 Dara Biosciences, Inc. Nanoemulsions comprising Spicamycin derivatives for use in the treatment of pain
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
EP2369923B1 (en) * 2008-11-26 2016-06-22 Viroblock SA Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
CA2750233A1 (en) 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
CN102458463B (zh) 2009-05-22 2017-01-18 健诺西生物科学公司 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法
CA2765511C (en) 2009-06-16 2015-05-12 The Regents Of The University Of Michigan Nanoemulsion vaccines
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US20110200683A1 (en) * 2010-02-16 2011-08-18 Piper Medical, Inc Hydrogen peroxide solution producing first aid substance, packaging, and treatment
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
WO2011116262A2 (en) * 2010-03-19 2011-09-22 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating urinary tract infections
AU2011254206B2 (en) 2010-05-20 2015-06-25 Ecolab Usa Inc. Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
JP2014520805A (ja) 2011-07-06 2014-08-25 ナノバイオ コーポレーション ヒト呼吸器合胞体ウイルスワクチン
WO2013028738A1 (en) 2011-08-22 2013-02-28 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
BR112014005406A2 (pt) 2011-09-09 2017-03-28 Nanobio Corp composição de vacina e respectivo uso
EP2782597B1 (en) 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CN102526139A (zh) * 2012-02-23 2012-07-04 华子昂 一种人工阴道液及其制备方法
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CN103830726A (zh) * 2012-11-23 2014-06-04 魏维 抗微生物有机纳米组合物及其制备方法
KR20140141857A (ko) * 2013-05-31 2014-12-11 한국생명공학연구원 패실로마이세스 속 균주를 이용한 생물 농약 제조방법
JP7158853B2 (ja) 2014-10-10 2022-10-24 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 対象における食物アレルギーまたは呼吸器アレルギーを処置するための、かつ上記対象の鼻腔内に投与するための免疫原性組成物
DK3289076T3 (da) 2015-05-01 2022-01-17 Prec Biosciences Inc Præcis sletning af kromosomale sekvenser in vivo
US11173197B2 (en) 2015-07-07 2021-11-16 Bluewillow Biologics, Inc. Methods and compositions for nanoemulsion vaccine formulations
CA2997909A1 (en) 2015-09-08 2017-03-16 Precision Biosciences, Inc. Treatment of retinitis pigmentosa using engineered meganucleases
CA3001008A1 (en) 2015-10-05 2017-04-13 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
AU2016333898B2 (en) 2015-10-05 2020-11-12 Precision Biosciences, Inc. Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
WO2017112859A1 (en) 2015-12-23 2017-06-29 Precision Biosciences, Inc. Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
US9981980B2 (en) 2016-04-27 2018-05-29 University Of Puerto Rico 1,5-Disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
WO2017192741A1 (en) 2016-05-03 2017-11-09 Precision Biosciences, Inc. Engineered nucleases useful for treatment of hemophilia a
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
JP6897031B2 (ja) * 2016-09-01 2021-06-30 住友ベークライト株式会社 防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES
EP3757120B8 (en) 2016-10-04 2022-06-15 Precision Biosciences, Inc. Co-stimulatory domains for use in genetically-modified cells
PE20191353A1 (es) 2016-10-14 2019-10-01 Prec Biosciences Inc Meganucleasas disenadas especificamente para el reconocimiento de secuencias en el genoma del virus de la hepatitis b
WO2018073393A2 (en) 2016-10-19 2018-04-26 Cellectis Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
IL301059A (en) 2017-04-21 2023-05-01 Prec Biosciences Inc Transgenic magnonucleases specific for recognition sequences in the PCSK9 gene
EP3615662A1 (en) 2017-04-28 2020-03-04 Precision Biosciences, Inc. Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells
CA3062698A1 (en) 2017-05-08 2018-11-15 Precision Biosciences, Inc. Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
WO2019005957A1 (en) 2017-06-30 2019-01-03 Precision Biosciences, Inc. GENETICALLY MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE ALPHA T CELL RECEPTOR GENE
JP7138702B2 (ja) 2017-09-22 2022-09-16 ベクトン・ディキンソン・アンド・カンパニー カテーテルロック溶液としての使用のための４％クエン酸三ナトリウム溶液
WO2019070856A1 (en) 2017-10-03 2019-04-11 Precision Biosciences, Inc. MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY MODIFIED CELLS
WO2019089913A1 (en) 2017-11-01 2019-05-09 Precision Biosciences, Inc. Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
JP7304888B2 (ja) 2018-04-12 2023-07-07 プレシジョン バイオサイエンシズ，インク． ヒトｔ細胞受容体アルファ定常領域遺伝子に特異性を有する最適化された操作されたヌクレアーゼ
TW201945388A (zh) 2018-04-12 2019-12-01 美商精密生物科學公司 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
EP3880173A1 (en) 2018-11-15 2021-09-22 Bluewillow Biologics, Inc. Nanoemulsion compositions having enhanced permeability
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
EP3898661A1 (en) 2018-12-21 2021-10-27 Precision BioSciences, Inc. Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
CN109845757A (zh) * 2019-03-15 2019-06-07 威海市农业科学院 果园用病虫害铲除剂及其制备方法、使用方法
WO2020206248A1 (en) 2019-04-03 2020-10-08 Precision Biosciences, Inc. Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
WO2021016608A1 (en) 2019-07-25 2021-01-28 Precision Biosciences, Inc. Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
AU2020333851A1 (en) 2019-08-20 2022-03-31 Precision Biosciences, Inc. Lymphodepletion dosing regimens for cellular immunotherapies
JP7101375B2 (ja) 2019-10-17 2022-07-15 タマ化学工業株式会社 除菌組成物及びそれを用いる細菌芽胞の除菌方法
WO2021087305A1 (en) 2019-10-30 2021-05-06 Precision Biosciences, Inc. Cd20 chimeric antigen receptors and methods of use for immunotherapy
US20230031465A1 (en) 2019-12-06 2023-02-02 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
WO2021113543A1 (en) 2019-12-06 2021-06-10 Precision Biosciences, Inc. Methods for cancer immunotherapy, using lymphodepletion regimens and cd19, cd20 or bcma allogeneic car t cells
CN111110631A (zh) * 2020-03-20 2020-05-08 苏国霞 一种高效广谱的抗菌纳米乳及其制备方法
US20230183664A1 (en) 2020-05-11 2023-06-15 Precision Biosciences, Inc. Self-limiting viral vectors encoding nucleases
CA3172171A1 (en) 2020-05-12 2021-11-18 Victor Bartsevich Treatment of retinitis pigmentosa using improved engineered meganucleases
EP4192875A1 (en) 2020-08-10 2023-06-14 Precision BioSciences, Inc. Antibodies and fragments specific for b-cell maturation antigen and uses thereof
WO2022040582A1 (en) 2020-08-21 2022-02-24 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
WO2022104062A1 (en) 2020-11-12 2022-05-19 Precision Biosciences, Inc. Engineered meganucleases having specificity for recognition sequences in the dystrophin gene
WO2022150616A1 (en) 2021-01-08 2022-07-14 Precision Biosciences, Inc. Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
EP4284823A1 (en) 2021-01-28 2023-12-06 Precision BioSciences, Inc. Modulation of tgf beta signaling in genetically-modified eukaryotic cells
WO2022226303A1 (en) 2021-04-22 2022-10-27 Precision Biosciences, Inc. Engineered meganucleases that target human mitochondrial genomes
KR20240010467A (ko) 2021-04-22 2024-01-23 프리시젼 바이오사이언시스 인코포레이티드 인간 미토콘드리아 게놈을 표적화하는 조작된 메가뉴클레아제
WO2023070002A2 (en) 2021-10-19 2023-04-27 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
WO2023070003A1 (en) 2021-10-19 2023-04-27 Precision Biosciences, Inc. Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
WO2023081767A1 (en) 2021-11-05 2023-05-11 Precision Biosciences, Inc. Methods for immunotherapy

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT986794B (it) * 1971-04-02 1975-01-30 Lepetit Spa Schiuma detergente ad azione tonificante
US4451267A (en) * 1982-09-29 1984-05-29 The United States Of America As Represented By The Secretary Of Agriculture Microemulsions from vegetable oil and aqueous alcohol with trialkylamine surfactant as alternative fuel for diesel engines
US4599088A (en) * 1984-08-30 1986-07-08 Texaco Inc. Clear stable gasoline-alcohol-water motor fuel composition
JPS63221835A (ja) * 1987-03-09 1988-09-14 Lion Corp 安定な水中油型エマルジヨンの製造方法
JP2506125B2 (ja) * 1987-10-06 1996-06-12 雄二 加藤 殺菌及び柔軟剤組成物
US4895452A (en) 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5103497A (en) 1989-11-14 1992-04-07 Hicks John W Flying spot endoscope
US5108660A (en) 1990-01-29 1992-04-28 The Procter & Gamble Company Hard surface liquid detergent compositions containing hydrocarbyl amidoalkylenesulfobetaine
US5709879A (en) 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
JPH05124910A (ja) * 1991-10-31 1993-05-21 Takeshi Uchibori 殺菌消毒液及びこれを用いる殺菌消毒材
JPH06279268A (ja) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd 消毒殺菌剤およびこれを含有するエアゾール組成物
JP3487359B2 (ja) * 1993-09-30 2004-01-19 株式会社資生堂 殺菌洗浄用組成物
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5368837A (en) 1994-04-14 1994-11-29 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
WO1995031966A1 (en) * 1994-05-20 1995-11-30 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5547677A (en) 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5549901A (en) 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
WO1997026855A1 (en) 1996-01-24 1997-07-31 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
US5662957A (en) 1996-05-03 1997-09-02 Novavax, Inc. Oil containing lipid vesicles with marine applications
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5700679A (en) 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
FR2750329B1 (fr) * 1996-06-28 1998-08-14 Oreal Emulsion huile-dans-eau ultrafine gelifiee et stabilisee par un poly(acide 2 -acrylamido 2 -methylpropane sulfonique) reticule et neutralise a au moins 90 %, procede de preparation et applications
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US6361787B1 (en) 1998-05-27 2002-03-26 The Clorox Company Enhanced antimicrobial composition
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections

Also Published As

Publication number Publication date
EP2364709A1 (en) 2011-09-14
CA2395678C (en) 2012-06-26
WO2001049296A1 (en) 2001-07-12
CN1433314B (zh) 2011-08-31
EP1242095A1 (en) 2002-09-25
JP2012136533A (ja) 2012-07-19
ES2425971T3 (es) 2013-10-18
AU2609901A (en) 2001-07-16
DK1242095T3 (da) 2013-08-12
MXPA02006564A (es) 2004-07-30
EP2364709B1 (en) 2012-11-28
JP2003519184A (ja) 2003-06-17
EP1242095A4 (en) 2005-03-16
US6506803B1 (en) 2003-01-14
JP5013495B2 (ja) 2012-08-29
EP1242095B1 (en) 2013-05-29
CN1433314A (zh) 2003-07-30
HK1055897A1 (en) 2004-01-30
CA2395678A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
BR0016796A (pt) Composições antimicrobianas e métodos de uso
ATE479419T1 (de) Wässrige dispersion wasserunlöslicher organischer uv-filtersubstanzen
CA2528095C (en) Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
BR0213877A (pt) Compostos orgânicos
ATE282109T1 (de) Wäschezusatzbeutel
MX247922B (es) Emulsiones agua en aceite que comprenden polimeros de vinilo que portan grupos de oxido de etileno en las cadenas laterales, composiciones y metodos.
DE60122341D1 (de) 9-substituierte minocyclinverbindungen
BR0113161A (pt) Arilóxi piperidinas não imidazóis
ES2143172T3 (es) Microemulsiones desinfectantes.
BRPI0815828A2 (pt) Formulação de emulsão que impede interação através da interface água-óleo
ES2119850T3 (es) Utilizacion de suavizantes acuosos para el tratamiento de textiles.
EA200500965A1 (ru) Микроэмульсионные концентраты
AR021624A1 (es) Composiciones para el lavado
AR008752A1 (es) Composicion acuosa liquida de uso agricola
AR017117A1 (es) Una composicion laminar, esferulitica o de fase l2, para su uso en fluidos de perforacion.
DE69814943D1 (de) Silizium enthaltende Verbindung und organische elektrolumineszente Vorrichtung, in welcher diese verwendet wird.
DOP2001000279A (es) Uso de polimerizados como auxiliares de filtracion y/o estabilizantes.
AR023447A1 (es) Dispersiones acuosas de productos quimicos agricolas
EA200300032A1 (ru) Распыляемая композиция для колерования
BRPI0511349A (pt) processo para melhorar fluìdos biológicos à prova de vìrus
CO5280225A1 (es) Composiciones cosmeticas
JP2003502588A5 (pt)
CO5660272A2 (es) Vacunas bovinas con adyuvantes
AR033538A1 (es) Composiciones para ahuyentar insectos rastreros
IT1311999B1 (it) Miscela liquida adatta come benzina.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]